Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets EXMKT - Delayed Quote USD

Viveve Medical, Inc. (VIVE)

0.0002
0.0000
(0.00%)
At close: April 28 at 4:00:00 PM EDT

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Martin Kerber P.E. Vice President of Research, Development & Operations -- -- --
Mr. Gary Kaiser Vice President of Global Marketing -- -- --
Ms. Suzon D. Lommel Senior Vice President of Regulatory & Quality Affairs -- -- 1958

Viveve Medical, Inc.

Building B
Suite 250 345 Inverness Drive South
Englewood, CO 80112
United States
720 696 8100 https://www.viveve.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
47

Description

Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.

Corporate Governance

Viveve Medical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

February 6, 2023 at 12:00 AM UTC

15-12G: Notice of termination of registration of a class of securities under Section 12(g)

January 27, 2023 at 12:00 AM UTC

POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

January 25, 2023 at 12:00 AM UTC

25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured

January 18, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 17, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 15, 2022 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 6, 2022 at 12:00 AM UTC

S-1/A: Offering Registrations

December 2, 2022 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 1, 2022 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 23, 2022 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers